1 January 2020 in Annals of Surgical Treatment and Research
Saydam O, et al. Ann Surg Treat Res. 2020 May;98(5):270-276. https://doi.org/10.4174/astr.2020.98.5.270
2 November 2022 in CardioVascular Journal of Africa
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 33, No 5, September/October 2022 254 AFRICA Endovascular treatment of Buerger’s disease in patients with critical limb
1 January 2021 in Annals of Surgical Treatment and Research
Serefli D, et al. Ann Surg Treat Res. 2021 Oct;101(4):247-255. https://doi.org/10.4174/astr.2021.101.4.247
12 November 2022 in Turkish Journal of Vascular Surgery
Venous aneurysm is very rare espacially inferior vena cava (IVC) aneurysm is extremely rare. Etiology is not clear and risk factors can be inflammatory disease, thrombosis, trauma and long term complication of long term right heart failure. Angiography with computer tomography (CTA), magnetic resonance angiography (MRA) and convantionel venography can use for diagnose.30 years old male patient admistered to clinic for lower abdominal pain for a month. Largest diameter in subhepatic region and left renal vein were 67mm and 26mm respectively. Literature there were limited numbers of case described. Because of this reason there was no quide or no adopted treatment aprroach was defined. Hardest and challenging part is giving the decision of treatment.
21 March 2021 in Archives of Medical Science
Introduction: The purpose of this study was to report the midterm outcomes of primary stenting of iliac arteries with additional factors which affect the outcome and to compare the results between patients with simple and complex aorta iliac occlusive disease (AOID). Material and methods:...
22 September 2021 in Turkish Journal of Vascular Surgery
Objectives: In this study, we present our clinical experience in patients with cancer-associated venous thrombosis (CAT) and aimed to conduct a meta-analysis to compare direct-acting oral anticoagulants (DOACs) with each other and low-molecular-weight heparin (LMWH).Patients and methods: Between January 2010 and December 2020, a total of 98 patients (44 males, 54 females; mean age: 65.6±13.4 years; range, 21 to 91 years) diagnosed with both cancer and venous thromboembolism (VTE) were screened in the computer-based database system. Randomized-controlled trials and clinical trials conducted between 2016 and 2020, in which DOACs were compared with LMWH in the treatment of VTE in cancer patients, were screened using the MEDLINE database via PubMed and SCOPUS.Results: Gynecological and gastrointestinal tract cancers were the most common malignancies in 22.4% and 28.6% of the patients, respectively). The rate of deep venous thrombosis (DVT) was higher (65.4%) and five patients had upper extremity DVT. Direct-acting oral anticoagulants were found to be more effective than LMWH in preventing recurrent VTE (risk ratio [RR]: 0.111; 95% confidence interval [CI]: 0.014-0.866; p=0.036 vs. RR: 0.444; 95% CI: 0.198-0.999; p=0.036, respectively).Conclusion: Based on our clinical experience and meta-analysis results, DOACs can be considered a reasonable alternative in patients with CAT. Clinicians should keep in mind that treatment of CAT requires a multidisciplinary approach and interdisciplinary collaboration.